发布求助
文献互助 智能选刊 最新文献

BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation最新文献

筛选
英文 中文
On the road with HIV: a guide for positive travelers. 艾滋病毒携带者之路:阳性旅行者指南。
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2007-01-01
Amelia Glynn
{"title":"On the road with HIV: a guide for positive travelers.","authors":"Amelia Glynn","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"19 4","pages":"40-5"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27109672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal complications of HIV/AIDS. 艾滋病毒/艾滋病的肾脏并发症。
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2007-01-01
Lynda Anne Szczech
{"title":"Renal complications of HIV/AIDS.","authors":"Lynda Anne Szczech","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Renal complications are common among people living with HIV; in fact, up to 30% of HIV positive individuals may have protein in their urine--a sign of kidney dysfunction. It is difficult to estimate precisely how many people develop kidney disease--and, therefore, to implement effective disease prevention or early intervention--because kidney dysfunction may be asymptomatic or may result in only vague symptoms, such as fatigue or general malaise. Without specific symptoms, many individuals are diagnosed later in their disease course, reducing the efficacy of available treatments. Given the risks associated with kidney disease, developing awareness of kidney function and getting the necessary tests are essential to maintaining good health with HIV. This article explains how kidney function is assessed, describes the renal complications that are most commonly seen in HIV positive people, and outlines treatment options.</p>","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"19 4","pages":"27-34"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27109668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conquering anxiety. 克服焦虑。
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2007-01-01
Joni Lavick, Gaetano Vaccaro
{"title":"Conquering anxiety.","authors":"Joni Lavick,&nbsp;Gaetano Vaccaro","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"19 2","pages":"20-8"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26711752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New approaches to HIV prevention. 预防艾滋病毒的新方法。
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2007-01-01
Liz Highleyman
{"title":"New approaches to HIV prevention.","authors":"Liz Highleyman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Just as the 1996 International AIDS Conference in Vancouver ushered in the era of effective combination antiretroviral therapy and the 2000 meeting in Durban focused on the HIV/AIDS epidemic in the developing world, the 2006 conference (held August 13-18 in Toronto) may be remembered as the one that brought HIV prevention to the fore. Political considerations aside, it has become abundantly clear that efforts to promote behavioral change--the so-called \"ABC\" approach, relying on abstinence, marital fidelity (\"be faithful\"), and condoms--has failed to stem the tide of new HIV infections. According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), some four million people worldwide were newly infected in 2005. Even as antiretroviral therapy begins to trickle down to people in resource-limited countries, public health experts estimate that about four people become infected with HIV for each person who starts treatment.</p>","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"19 2","pages":"29-38"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26711753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human papillomavirus. 人类乳头状瘤病毒。
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2007-01-01
Liz Highleyman
{"title":"Human papillomavirus.","authors":"Liz Highleyman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A majority of sexually active adults carry the human papillomavirus (HPV), but until recently, this virus received little public attention. This changed in 2006 with the approval of a new vaccine that can prevent infection with certain types of HPV, and thereby reduce the risk of cervical cancer.</p>","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"19 4","pages":"35-9"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27109669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TH9507: an experimental treatment for lipodystrophy. TH9507:一种实验性治疗脂肪营养不良的药物。
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2007-01-01
Anne Monroe
{"title":"TH9507: an experimental treatment for lipodystrophy.","authors":"Anne Monroe","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>As the use of highly active antiretroviral therapy (HAART) became widespread, HIV positive individuals and their physicians began to notice changes in body fat distribution, with excess fat or fat loss noted in different areas. These body shape changes are sometimes accompanied by metabolic abnormalities, such as insulin resistance and elevated blood fats. Collectively, these changes are known as lipodystrophy syndrome. Treatment options for lipodystrophy are somewhat limited. Growth hormone has been used with success in clinical trials to reduce visceral adipose tissue, fat that collects around the abdominal organs. A new product, TH9507, a synthetic growth hormone releasing hormone analog made by the Canadian pharmaceutical company Theratechnologies, is currently showing promise in clinical trials and may represent a new treatment option for people with some types of lipodystrophy.</p>","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"19 4","pages":"16-9"},"PeriodicalIF":0.0,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27109664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revisiting monotherapy: heresy or revised orthodoxy? 重新审视单一疗法:异端还是修正的正统?
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2006-01-01
Bob Huff
{"title":"Revisiting monotherapy: heresy or revised orthodoxy?","authors":"Bob Huff","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>After the widespread introduction of triple combination antiretroviral therapy in 1996 caused AIDS deaths to plummet, the earlier practice of single-drug treatment--or monotherapy--seemed like an embarrassing phase of medical ignorance. By then, it had become all too apparent that monotherapy promoted the rapid development of drug-resistant virus, often leading to treatment failure. Stories still occasionally surface about an isolated doctor prescribing solo AZT (zidovudine, Retrovir), and many long-time HIV physicians with large practices probably have one or two patients still doing well on two drugs and see no reason to change their regimens. But by and large, hitting hard with two nucleoside reverse transcriptase inhibitors (NRTIs) plus either a protease inhibitor (PI) or a non-NRTI (NNRTI) has become dogma, and is now enshrined in all HIV treatment guidelines.</p>","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"18 2","pages":"15-7"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25969506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MK-0518 and GS-9137: two promising integrase inhibitors in the pipeline. MK-0518和GS-9137:两种有前景的整合酶抑制剂
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2006-01-01
Reilly O'Neal
{"title":"MK-0518 and GS-9137: two promising integrase inhibitors in the pipeline.","authors":"Reilly O'Neal","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Possibly the most exciting news to come out of the 13th Conference on Retroviruses and Opportunistic Infections, held in Denver last February, concerned clinical trials of two experimental drugs in a new class: integrase inhibitors. If successful in further trials, integrase inhibitors could revitalize the treatment regimens of people living with multidrug-resistant HIV.</p>","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"18 4","pages":"13-6"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26290899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methamphetamine and HIV. 甲基苯丙胺和艾滋病毒。
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2006-01-01
Bob Huff
{"title":"Methamphetamine and HIV.","authors":"Bob Huff","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>When the New York City Department of Health and Mental Hygiene announced in January 2005 that a gay man in his forties had become infected with a multidrug-resistant \"superstrain\" of HIV and had progressed to AIDS within a few months, much was made of the man's use of methamphetamine. The case highlighted two important aspects of the intersection of methamphetamine use and HIV. First is the fairly well-established role the drug can play in facilitating new infections by lowering users' inhibitions and encouraging sexual practices that increase the risk of HIV transmission. The second aspect is the idea that methamphetamine somehow speeds up the HIV disease process. There is little evidence of a direct interaction between meth and HIV that accelerates immune decline, but meth use can undermine the general health of the user. There is also a growing body of evidence that meth's harmful effects on the brain may be exacerbated in people with HIV, and that many HIV-related neurological impairments may be worsened by meth use.</p>","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"18 4","pages":"42-7"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26290903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Switching antiretroviral therapy. 转换抗逆转录病毒治疗。
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation Pub Date : 2006-01-01
Liz Highleyman
{"title":"Switching antiretroviral therapy.","authors":"Liz Highleyman","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":80644,"journal":{"name":"BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation","volume":"18 4","pages":"17-29"},"PeriodicalIF":0.0,"publicationDate":"2006-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"26290900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信